Evaluation of Three Mutations in Codon 385 of Glucose-6-Phosphate Dehydrogenase via Biochemical and In Silico Analysis
Authors:
- Adriana Gálvez-RamírezAGAdriana Gálvez-Ramírez
- Abigail González-ValdezAGAbigail González-Valdez
- Beatriz Hernández-OchoaBHBeatriz Hernández-Ochoa
- Luis Miguel Canseco-ÁvilaLCLuis Miguel Canseco-Ávila
- Alexander López-RobleroALAlexander López-Roblero
- Roberto Arreguin-EspinosaRoberto Arreguin-Espinosa
- Verónica Pérez de la CruzVerónica Pérez de la Cruz
- Elizabeth Hernández-UrzuaEHElizabeth Hernández-Urzua
- Noemi Cárdenas-RodríguezNoemi Cárdenas-Rodríguez
- Sergio Enríquez-FloresSESergio Enríquez-Flores
- Ignacio De la Mora-De la MoraIMIgnacio De la Mora-De la Mora
- Abraham Vidal-LimonAbraham Vidal-Limon
Open Access
- 22 November 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (23) , 12556
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an enzymopathy that affects approximately 500 million people worldwide. A great number of mutations in the G6PD gene have been described. However, three class A G6PD variants known as G6PD Tomah (C385R), G6PD Kangnam (C385G), and G6PD Madrid (C385W) have been reported to be clinically important due to their associations with severe clinical manifestations such as hemolytic anemia. Therefore, this work aimed to perform, for the first time, biochemical and functional characterizations of these variants. The G6PD variants were cloned and purified for this purpose, followed by analyses of their kinetic parameters and thermal stability, as well as in silico studies. The results showed that the mutations induced changes in the proteins. Regarding the kinetic parameters, it was observed that the three variants showed lower affinities for G6P and NADP+, as well as lower thermal stability compared to WT-G6PD. Molecular dynamics simulations showed that C385 mutations induced changes around neighboring amino acids. Metadynamics simulations showed that most remarkable changes account for the binding pocket volumes, particularly in the structural NADP+ binding site, with a concomitant loss of affinity for catalytic processes.Keywords
Funding Information
- Recursos Fiscales para la Investigación, E022 Program (034/2022, TKII-AMVL001)
- HIM/2019/036 SSA. 1595 (034/2022, TKII-AMVL001)
- National Supercomputing Center—IPICYT (034/2022, TKII-AMVL001)
This publication has 49 references indexed in Scilit:
- A computational study of structural analysis of Class I human glucose-6-phosphate dehydrogenase (G6PD) variants: Elaborating the correlation to chronic non-spherocytic hemolytic anemia (CNSHA)Computational Biology and Chemistry, 2023
- LambdaPP: Fast and accessible protein‐specific phenotype predictionsProtein Science, 2022
- Functional characterization of the p.(Gln195His) or Tainan and novel p.(Ser184Cys) or Toluca glucose-6-phosphate dehydrogenase (G6PD) gene natural variants identified through Mexican newborn screening for glucose-6-phosphate dehydrogenase deficiencyClinical Biochemistry, 2022
- A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiencyInternational Journal of Biological Macromolecules, 2017
- Glucose-6-phosphate dehydrogenase deficiency in northern Mexico and description of a novel mutationJournal of Genetics, 2014
- G6PD Deficiency2013
- Glucose-6-phosphate dehydrogenase (G6PD) mutations database: Review of the “old” and update of the new mutationsBlood Cells, Molecules, and Diseases, 2012
- Clinical mutants of human glucose 6-phosphate dehydrogenase: Impairment of NADP+ binding affects both folding and stabilityBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and NashvilleBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- In vivo gene marking of rhesus macaque long‐term repopulating hematopoietic cells using a VSV‐G pseudotyped versus amphotropic oncoretroviral vectorThe Journal of Gene Medicine, 2004